Cargando…

Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas

Background: Neuron glial antigen 2 or chondroitin sulphate proteoglycan 4 (NG2/CSPG4) is expressed by immature precursors/progenitor cells and is possibly involved in malignant cell transformation. The aim of this study was to investigate its role on the progression and survival of sixty-one adult g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mellai, Marta, Annovazzi, Laura, Bisogno, Ilaria, Corona, Cristiano, Crociara, Paola, Iulini, Barbara, Cassoni, Paola, Casalone, Cristina, Boldorini, Renzo, Schiffer, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349878/ https://www.ncbi.nlm.nih.gov/pubmed/32599896 http://dx.doi.org/10.3390/cells9061538

Ejemplares similares

The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas
por: Schiffer, Davide, et al.
Publicado: (2018)

Theranostic Impact of NG2/CSPG4 Proteoglycan in Cancer
por: Nicolosi, Pier Andrea, et al.
Publicado: (2015)

Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan
por: Leoni, Giampaolo, et al.
Publicado: (2014)

Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage
por: Hsu, Shu-Hsuan Claire, et al.
Publicado: (2018)

Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF
por: Uranowska, Karolina, et al.
Publicado: (2021)

Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors
por: Keleg, Shereen, et al.
Publicado: (2014)

SEL1L plays a major role in human malignant gliomas
por: Mellai, Marta, et al.
Publicado: (2019)

Glioblastoma: Microenvironment and Niche Concept
por: Schiffer, Davide, et al.
Publicado: (2018)

Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
por: Wang, Jian, et al.
Publicado: (2011)

The regulatory mechanisms of NG2/CSPG4 expression
por: Ampofo, Emmanuel, et al.
Publicado: (2017)

Immunohistochemical localization of chondroitin sulphate and dermatan sulphate proteoglycans in tumour tissues.
por: Fukatsu, T., et al.
Publicado: (1988)

NgR1 and NgR3 are Receptors for Chondroitin Sulfate Proteoglycans
por: Dickendesher, Travis L., et al.
Publicado: (2012)

Chondroitin Sulfate Proteoglycan-4 (CSPG4)-Specific Monoclonal Antibody 225.28 in Detection of Acute Myeloid Leukemia Blasts
por: Fenton, Moon, et al.
Publicado: (2015)

VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen
por: Nounamo, Bernice, et al.
Publicado: (2023)

Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen
Publicado: (1990)

Immunotherapeutic Targeting of NG2/CSPG4 in Solid Organ Cancers
por: Zhang, Hongyu, et al.
Publicado: (2022)

Chondroitin Sulphate Proteoglycan Axonal Coats in the Human Mediodorsal Thalamic Nucleus
por: Pantazopoulos, Harry, et al.
Publicado: (2022)

NG2/CSPG4 regulates cartilage degeneration during TMJ osteoarthritis
por: Reed, David A., et al.
Publicado: (2022)

Chondroitin Sulphate/Dermatan Sulphate Proteoglycans: Potential Regulators of Corneal Stem/Progenitor Cell Phenotype In Vitro
por: Bains, Kiranjit K., et al.
Publicado: (2023)

GM-CSF reduces expression of chondroitin sulfate proteoglycan (CSPG) core proteins in TGF-β-treated primary astrocytes
por: Choi, Jung-Kyoung, et al.
Publicado: (2014)

A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
por: Hoffmann, Ricarda M., et al.
Publicado: (2020)

“On-The-Spot” Arresting of Chondroitin Sulphate Proteoglycans: Implications for Ovarian Adenocarcinoma Recognition and Intervention
por: Pradeep, Priyamvada, et al.
Publicado: (2016)

Glucocorticoids influence versican and chondroitin sulphate proteoglycan levels in the fetal sheep lung
por: McDougall, Annie R. A., et al.
Publicado: (2018)

Perineuronal Nets in Spinal Motoneurones: Chondroitin Sulphate Proteoglycan around Alpha Motoneurones
por: Irvine, Sian F., et al.
Publicado: (2018)

Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres
por: Caldera, Valentina, et al.
Publicado: (2011)

Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?
por: Mellai, Marta, et al.
Publicado: (2015)

NG2/CSPG4 attenuates motility in mandibular fibrochondrocytes under serum starvation conditions
por: Ahn, Shin Young, et al.
Publicado: (2023)

Comparison among conventional and advanced MRI, (18)F-FDG PET/CT, phenotype and genotype in glioblastoma
por: Valentini, Maria Consuelo, et al.
Publicado: (2017)

Promoter Hypermethylation of the EMP3 Gene in a Series of 229 Human Gliomas
por: Mellai, Marta, et al.
Publicado: (2013)

The Association between Genes Polymorphisms of Heparan Sulfate Proteoglycan 2 (HSPG2) and Chondroitin Sulfate Proteoglycan 2 (CSPG2) and Intracranial Aneurysm Susceptibility: A Meta-Analysis
por: LIU, Huahui, et al.
Publicado: (2019)

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
por: Farnedi, Anna, et al.
Publicado: (2015)

Biosynthesis of Promatrix Metalloproteinase-9/Chondroitin Sulphate Proteoglycan Heteromer Involves a Rottlerin-Sensitive Pathway
por: Malla, Nabin, et al.
Publicado: (2011)

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma
por: Svendsen, Agnete, et al.
Publicado: (2011)

Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
por: Poli, Aurélie, et al.
Publicado: (2013)

Diversified Expression of NG2/CSPG4 Isoforms in Glioblastoma and Human Foetal Brain Identifies Pericyte Subsets
por: Girolamo, Francesco, et al.
Publicado: (2013)

New Insights Into Human Hyaluronidase 4/Chondroitin Sulphate Hydrolase
por: Maciej-Hulme, Marissa L.
Publicado: (2021)

Correction: Diversified Expression of NG2/CSPG4 Isoforms in Glioblastoma and Human Foetal Brain Identifies Pericyte Subsets
Publicado: (2014)

Myelin Debris Stimulates NG2/CSPG4 Expression in Bone Marrow-Derived Macrophages in the Injured Spinal Cord
por: Liu, Yang, et al.
Publicado: (2021)

SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
por: Mellai, Marta, et al.
Publicado: (2015)

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
por: Mellai, Marta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q314gsk4v9tie28a7e4651sg5o